世界のOTC抗感染製品市場2020:製造企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC07503)
◆英語タイトル:Global OTC Anti-Infective Products Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC07503
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:101
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、OTC抗感染製品の世界市場を調査対象にし、OTC抗感染製品の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(抗真菌剤、防腐剤、駆虫剤)、用途別分析(病院薬局、ドラッグストア、小売店、電子商取引)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:GlaxoSmithKline、Roche、Novartis、Merck、Bristol-Myers Squibb、Pfizer、Novabay Pharmaceuticals、Sanofi、Abbott、NanoViricides、Optimer Pharmaceuticals、Basilea Pharmaceutica、MerLion Pharma
・メーカー別販売量、売上、市場シェア
・OTC抗感染製品の地域別市場分析
・OTC抗感染製品の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・OTC抗感染製品のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・OTC抗感染製品のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・OTC抗感染製品の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・OTC抗感染製品の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・OTC抗感染製品の種類別市場規模2015-2020:抗真菌剤、防腐剤、駆虫剤
・OTC抗感染製品の用途別市場規模2015-2020:病院薬局、ドラッグストア、小売店、電子商取引
・OTC抗感染製品の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The global OTC Anti-Infective Products market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The OTC Anti-Infective Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
OTC Anti-Infective Products market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, OTC Anti-Infective Products market has been segmented into
Antifungals
Antiseptic
Antiparasitics

By Application, OTC Anti-Infective Products has been segmented into:
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global OTC Anti-Infective Products market presented in the report. This section sheds light on the sales growth of different regional and country-level OTC Anti-Infective Products markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global OTC Anti-Infective Products market.

The report offers in-depth assessment of the growth and other aspects of the OTC Anti-Infective Products market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and OTC Anti-Infective Products Market Share Analysis
OTC Anti-Infective Products competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, OTC Anti-Infective Products sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the OTC Anti-Infective Products sales, revenue and market share for each player covered in this report.

The major players covered in OTC Anti-Infective Products are:
GlaxoSmithKline
Roche
Novartis
Merck
Bristol-Myers Squibb
Pfizer
Novabay Pharmaceuticals
Sanofi
Abbott
NanoViricides
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma

Among other players domestic and global, OTC Anti-Infective Products market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe OTC Anti-Infective Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of OTC Anti-Infective Products, with price, sales, revenue and global market share of OTC Anti-Infective Products in 2018 and 2019.
Chapter 3, the OTC Anti-Infective Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Anti-Infective Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, OTC Anti-Infective Products market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe OTC Anti-Infective Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 OTC Anti-Infective Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global OTC Anti-Infective Products Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market Analysis by Application
1.3.1 Overview: Global OTC Anti-Infective Products Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Overview of Global OTC Anti-Infective Products Market
1.4.1 Global OTC Anti-Infective Products Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novabay Pharmaceuticals
2.7.1 Novabay Pharmaceuticals Details
2.7.2 Novabay Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novabay Pharmaceuticals SWOT Analysis
2.7.4 Novabay Pharmaceuticals Product and Services
2.7.5 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SWOT Analysis
2.8.4 Sanofi Product and Services
2.8.5 Sanofi OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott SWOT Analysis
2.9.4 Abbott Product and Services
2.9.5 Abbott OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 NanoViricides
2.10.1 NanoViricides Details
2.10.2 NanoViricides Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 NanoViricides SWOT Analysis
2.10.4 NanoViricides Product and Services
2.10.5 NanoViricides OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Optimer Pharmaceuticals
2.11.1 Optimer Pharmaceuticals Details
2.11.2 Optimer Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Optimer Pharmaceuticals SWOT Analysis
2.11.4 Optimer Pharmaceuticals Product and Services
2.11.5 Optimer Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Basilea Pharmaceutica
2.12.1 Basilea Pharmaceutica Details
2.12.2 Basilea Pharmaceutica Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Basilea Pharmaceutica SWOT Analysis
2.12.4 Basilea Pharmaceutica Product and Services
2.12.5 Basilea Pharmaceutica OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 MerLion Pharma
2.13.1 MerLion Pharma Details
2.13.2 MerLion Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 MerLion Pharma SWOT Analysis
2.13.4 MerLion Pharma Product and Services
2.13.5 MerLion Pharma OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global OTC Anti-Infective Products Sales and Market Share by Manufacturer (2018-2019)
3.2 Global OTC Anti-Infective Products Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 OTC Anti-Infective Products Manufacturer Market Share in 2019
3.3.2 Top 6 OTC Anti-Infective Products Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global OTC Anti-Infective Products Sales, Revenue and Market Share by Regions
4.1.1 Global OTC Anti-Infective Products Sales and Market Share by Regions (2015-2020)
4.1.2 Global OTC Anti-Infective Products Revenue and Market Share by Regions (2015-2020)
4.2 North America OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
4.3 Europe OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
4.5 South America OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America OTC Anti-Infective Products Sales, Revenue and Market Share by Country
5.1.1 North America OTC Anti-Infective Products Sales and Market Share by Country (2015-2020)
5.1.2 North America OTC Anti-Infective Products Revenue and Market Share by Country (2015-2020)
5.2 United States OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
5.3 Canada OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
5.4 Mexico OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe OTC Anti-Infective Products Sales, Revenue and Market Share by Country
6.1.1 Europe OTC Anti-Infective Products Sales and Market Share by Country (2015-2020)
6.1.2 Europe OTC Anti-Infective Products Revenue and Market Share by Country (2015-2020)
6.2 Germany OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6.3 UK OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6.4 France OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6.5 Russia OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
6.6 Italy OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific OTC Anti-Infective Products Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific OTC Anti-Infective Products Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific OTC Anti-Infective Products Revenue and Market Share by Regions (2015-2020)
7.2 China OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.3 Japan OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.4 Korea OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.5 India OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.6 Southeast Asia OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
7.7 Australia OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America OTC Anti-Infective Products Sales, Revenue and Market Share by Country
8.1.1 South America OTC Anti-Infective Products Sales and Market Share by Country (2015-2020)
8.1.2 South America OTC Anti-Infective Products Revenue and Market Share by Country (2015-2020)
8.2 Brazil OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
8.3 Argentina OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa OTC Anti-Infective Products Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa OTC Anti-Infective Products Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa OTC Anti-Infective Products Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
9.3 Turkey OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
9.4 Egypt OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
9.5 South Africa OTC Anti-Infective Products Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global OTC Anti-Infective Products Sales and Market Share by Type (2015-2020)
10.2 Global OTC Anti-Infective Products Revenue and Market Share by Type (2015-2020)
10.3 Global OTC Anti-Infective Products Price by Type (2015-2020)
11 Global OTC Anti-Infective Products Market Segment by Application
11.1 Global OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
11.2 Global OTC Anti-Infective Products Revenue Market Share by Application (2015-2020)
11.3 Global OTC Anti-Infective Products Price by Application (2015-2020)
12 Market Forecast
12.1 Global OTC Anti-Infective Products Sales, Revenue and Growth Rate (2021-2025)
12.2 OTC Anti-Infective Products Market Forecast by Regions (2021-2025)
12.2.1 North America OTC Anti-Infective Products Market Forecast (2021-2025)
12.2.2 Europe OTC Anti-Infective Products Market Forecast (2021-2025)
12.2.3 Asia-Pacific OTC Anti-Infective Products Market Forecast (2021-2025)
12.2.4 South America OTC Anti-Infective Products Market Forecast (2021-2025)
12.2.5 Middle East & Africa OTC Anti-Infective Products Market Forecast (2021-2025)
12.3 OTC Anti-Infective Products Market Forecast by Type (2021-2025)
12.3.1 Global OTC Anti-Infective Products Sales Forecast by Type (2021-2025)
12.3.2 Global OTC Anti-Infective Products Market Share Forecast by Type (2021-2025)
12.4 OTC Anti-Infective Products Market Forecast by Application (2021-2025)
12.4.1 Global OTC Anti-Infective Products Sales Forecast by Application (2021-2025)
12.4.2 Global OTC Anti-Infective Products Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のOTC抗感染製品市場2020:製造企業別、地域別、種類別、用途別、市場予測2025(Global OTC Anti-Infective Products Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。